Deﬁnitions of the MetS by the WHO, EGIR, NCEP, ACE, IDF, and updated NCEP criteria Wang J, et al. Eur Heart J 2007;28:857-64.

Slides:

Advertisements

Similar presentations

1 Baseline BMI and Age-Adjusted Incidence of Diabetes Mellitus White Men Level of BMI Percent

Advertisements

1 SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2) Enalapril/ACEI vs. HCTZ, n = 6,083 Randomized, open-label (blinded endpoint review) All CV events.

Ian Graham et al. European Heart Journal 2007;28:

Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology Nathan D. Wong, PhD, FACC, FAHA Professor and Director.

METABOLIC SYNDROME, INCIDENCE OF DIABETES AND MORTALITY AMONG ELDERLY: THE ITALIAN LONGITUDINAL STUDY ON AGING M Noale, S Maggi, F Limongi, P Siviero,

The Burden and Contributors to Cardiovascular Disease and Diabetes in Indigenous Australians Alex Brown Baker IDI.

Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP

VBWG Predictor of CV Events and Mortality in Postmenopausal Women: Leukocyte Count.

Enrollment, Randomization, and Follow-up of Study Participants ADVANCE Collaborative Group. N Engl J Med 2008;358:

Age-standardized mortality from ischaemic heart disease in European regions (men; age group years; year 2000) J Muller-Nordhorn, et al. Eur Heart.

Baseline Prevalence of Metabolic Syndrome and Individual Components Among 4258 Older Adults Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:

Trial profile Prakash Deedwania, et al. Lancet 2006; 368:

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.

Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.

CHOICE: Relative risk of death on peritoneal dialysis vs hemodialysis

Adjusted mortality risk

WHI Observational Study: Cardiovascular death in women with hypertension but no history of CVD on monotherapy CVD death Diuretic, HR (95% CI) ACE inhibitor,

اتجاهات أنماط المرض بين السكان. المراحل الأربع للتحول الوبائى.

Association between highest tertile for homocysteine and mortality

Description of studies for pooled analyses

Fung TT, et al. Circulation 2009;119:

P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Level of risk factor control in the overall sample and by gender

David J.A. Jenkins et al. JACC 2018;71:

NAFLD (nonalcoholic fatty liver disease), CVD, and type 2 diabetes: Details of the study design Targher G et al. Diabetes Care 2007;30:

Risk for BMI outcome (%)

Baseline Characteristics of 400 Women Who Subsequently Developed Incident Hypertension (Case Subjects) and 400 Women Who Remained Free of Hypertension.

Baseline Characteristics

Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.

Gender differences in diabetes prevalence in 2009 in the general Portuguese population patients and in patients with CAP. Diabetes prevalence is higher.

Distribution of Cardiovascular Risk Factors by Baseline CRP Concentration M. Cushman et al. Circulation. 2005;112:25-31.

Baseline Characteristics According to Sex

Baseline Characteristics of Study Subjects

Baseline Characteristics

Age-specific mortality rates from CHD and stroke in women and men in 2010 in selected countries. Age-specific mortality rates from CHD and stroke in women.

Glycated Hemoglobin Levels (A1C)

Kaplan-Meier plots of hHF: DPP-4i and SU cohort with baseline CVD (panel A); saxagliptin and sitagliptin cohorts with baseline CVD (panel B); DPP-4i and.

Baseline Lipid Parameters and Characteristics Among 3110 Men According to Quintiles of Total Cholesterol Ruben O. Halperin et al, Hypertension 2006;47;45-50.

Baseline characteristics of older women (NHS I), younger women (NHS II), and men (HPFS) with a history of hypertension according to thiazide use Eric N.

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.

Kaplan-Meier curve of cumulative percentage of cardiac mortality by peak flow rate category (adjusted HRs (95% CI) compared with ≥550 L/min: (

Flow chart of search strategy

Kaplan–Meier plots of 5 and 12-year all cause (A and C, respectively) and cardiovascular mortality (B and D, respectively) with number of participants.

Kaplan-Meier survival curves for non-fatal stroke or mortality based on IMRS categories among (A) women (p-trend

Lifetime heart failure risk*

Receiver-operating characteristic curves showing the performance of the diabetes risk score in predicting diabetes in the United Arab Emirates (UAE) citizens.

Adjusted HRs (95% CIs) for all-cause mortality associated with BMI by smoking status in men and women and by CHD, type 2 diabetes, and cancer status at.

Two-year changes in albumin-to-creatinine ratio across microalbuminuria at baseline. Two-year changes in albumin-to-creatinine ratio across microalbuminuria.

The prevalence of type 2 diabetes for R1420H carriers and noncarriers in relation to BMI. Diabetes prevalence is shown in individuals stratified by their.

Adjusted HRs (95% CIs) for all-cause mortality associated with body fat percentage by smoking status in men and women and by CHD, type 2 diabetes, and.

Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.

Increase of physical activity over time associated with lower HF risk

Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.

Kaplan-Meier survival curve for CVD mortality among physically active and inactive type 2 diabetic patients stratified by baseline hs-CRP levels. Kaplan-Meier.

Prasugrel versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR

Kaplan-Meir survival plots for CHD mortality (A), CVD mortality (B), and all-cause mortality (C) in men grouped by TG/HDL-C ratio of 3.5. Kaplan-Meir survival.

Adjusted all-cause (A) and CVD (B) mortality HRs (95% CIs) for IFG, IGT, NDM, and KDM compared with NGT according to ethnic group. Adjusted all-cause (A)

Subgroup analysis of associations between egg consumption and risk of incident cardiovascular disease (CVD), ischaemic heart disease (IHD), haemorrhagic.

Association of body mass index with all-cause mortality in diabetes and non-diabetes populations, by smoking status. Association of body mass index with.

Percentage of total mortality cases from CHD, CVD, and other causes (A). Percentage of total mortality cases from CHD, CVD, and other causes (A). Mortality.

Independent predictors of all-cause mortality at 30 days.

Prevalence of nephropathy, retinopathy, and neuropathy in subjects achieving all (A) three targets, (B) two targets, (C) one target, and (D) none, and.

Adjusted ORs of increasing severity of heartburn at follow-up in reference to baseline from model adjusted for BMI category, CVD history, BDI score >11,

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Presentation transcript:

Deﬁnitions of the MetS by the WHO, EGIR, NCEP, ACE, IDF, and updated NCEP criteria Wang J, et al. Eur Heart J 2007;28:857-64

Baseline characteristics of subjects who died of CHD, CVD or any cause, and risk factors for CHD, CVD, and all-cause mortality during the 13-year follow-up in 1025 non-diabetic subjects (univariable Cox regression analysis) Wang J, et al. Eur Heart J 2007;28:857-64

HRs and their 95% CI (in parentheses) of the MetS deﬁned by the WHO, EGIR, NCEP, ACE, IDF, and updated NCEP criteria for CHD, CVD, and all-cause mortality during the 13-year follow-up in 1025 non-diabetic subjects (percentage in parentheses after each deﬁnition is the prevalence of the MetS) Wang J, et al. Eur Heart J 2007;28:857-64

HRs of the MetS deﬁned by the WHO, EGIR, NCEP, ACE, IDF and updated NCEP criteria for CHD, CVD, and all-cause mortality during the 13-year follow-up in 377 non-diabetic men and 648 non-diabetic women Wang J, et al. Eur Heart J 2007;28:857-64

HRs of individual components of the MetS for CVD mortality based on the WHO, EGIR, NCEP, ACE, IDF, and updated NCEP criteria in 1025 non-diabetic subjects Wang J, et al. Eur Heart J 2007;28:857-64